Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 10:19:981-996.
doi: 10.2147/PPA.S514283. eCollection 2025.

Predictors of Medication Non-Adherence Among Hepatitis B Patients in South Sudan: A Health-Facility-Based Cross-Sectional Study

Ismail Bamidele Afolabi  1   2 , Abdulmujeeb Babatunde Aremu  3 , Musa Jal-Paul Koryom  1   4 , Amos Buh  2 , Shannon A Bainbridge  2   5 , Karen P Phillips  2
Affiliations

Predictors of Medication Non-Adherence Among Hepatitis B Patients in South Sudan: A Health-Facility-Based Cross-Sectional Study

Ismail Bamidele Afolabi et al. Patient Prefer Adherence. .

Abstract

Background: Despite the effectiveness of hepatitis B virus (HBV) antiviral treatment therapy in reducing the risk of liver-related complications, such as cirrhosis and hepatocellular carcinoma among chronically infected patients, medication non-adherence continues to hamper the successful management of the infection. The extent of HBV treatment adherence, associated facilitators, and barriers in South Sudan is not established. This study aimed to explore the predictors of medication non-adherence among HBV patients attending a public health facility in, South Sudan.

Methods: We conducted a facility-based cross-sectional study of 392 convenience-selected patients using a pretested interviewer-administered questionnaire premised on the information-motivation-behavioral skills (IMB) adherence model between December 2023 and March 2024. The relationship between medication non-adherence and antecedent variables was ascertained by logistic regression analysis.

Results: The sample was predominantly male (64.3%), and the mean age was 31.06 (30.19-31.93) years, with 28.1% reporting no formal education. The patients demonstrated inadequate HBV information (4.33±1.93), low motivation (8.20±2.69), and inadequate behavioral skills toward medication adherence (8.45±2.99), as measured on their respective rating scales. Further, more than two-thirds of the patients (70.2%) were HBV medication non-adherent. Younger age (AOR = 4.74, 95% CI = 2.13-10.56), being currently unmarried (AOR = 3.25, 95% CI = 1.76-6.01), unemployment (AOR = 4.19, 95% CI = 1.84-9.56), and increased behavioral skills (AOR = 1.12, 95% CI = 1.84-9.56) significantly influenced medication non-adherence. Lower education (AOR = 0.21, 95% CI = 0.10-0.46) and information adequacy (AOR = 0.63, 95% CI = 0.53-0.75) were associated with lower odds of non-adherence.

Conclusion: The study highlights key factors influencing the concerning rate of medication non-adherence among HBV patients in South Sudan. While these identified factors may explain the lingering burden of HBV-related complications, targeted interventions addressing demographic, socioeconomic barriers, and HBV-specific education are essential to enhance adherence and improve health outcomes.

Keywords: South Sudan; behavioral skills; hepatitis B; information adequacy; medication non-adherence; treatment therapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests for this work.

Figures

Figure 1
Figure 1
Conceptual Framework derived from IMB model for the diagnosis of health outcomes related to HBV infection via medication adherence.
Figure 2
Figure 2
Relationship between IMB predictor variables and - medication non-adherence. Note: *p≤0.05; significant relationships in the connections between the variables, as determined by linear correlation and logistic regression analyses.
Figure 3
Figure 3
Level of medication adherence and IMB predictor scores among adherent and non-adherent patients.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Liu J, Liang W, Jing W, Liu M. Countdown to 2030: eliminating Hepatitis B Disease, China. Bulletin of the World Health Organization. 2019;97(3):230–238. doi:10.2471/BLT.18.219469 - DOI - PMC - PubMed
    1. Bancha B, Kinfe AA, Chanko KP, Workie SB, Tadese T. Prevalence of hepatitis B viruses and associated factors among pregnant women attending antenatal clinics in public hospitals of Wolaita Zone, South Ethiopia. PLoS One. 2020;15(5):e0232653. doi:10.1371/journal.pone.0232653 - DOI - PMC - PubMed
    1. World Health Organization, WHO. (2022). Hepatitis B. WHO Fact sheet. Accessed 11, August 2024. Available from.: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b.
    1. Lemoine M, Eholié S, Lacombe K. Reducing the neglected burden of viral hepatitis in Africa: strategies for a global approach. J Hepatol. 2015;62(2):469–476. doi:10.1016/j.jhep.2014.10.008 - DOI - PubMed
    1. Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet (London, England). 2015;386(10003):1546–1555. doi:10.1016/S0140-6736(15)61412-X - DOI - PubMed

LinkOut - more resources